Company profile
ariadne.ai AG
Our multidisciplinary team of neuroscientists and machine-learning experts combines human and artificial intelligence to turn terabytes of histopathological microscopy data of cell cultures and neural tissue into quantitative results. We develop and offer cutting-edge image processing technology - scalable in throughput, consistent in quality. Among our newest products is LMtrace® a versatile biomarker for neurological diseases that is based on neuron shape analysis. LMtrace® is going to reduce the failure rates for drug discovery programs for brain diseases tremendously.
Source: startup.ch